FATE

Fate Therapeutics Inc $2.34 1M -7.1% 3M +13.6% YTD +136.4% as of 2026-09-14
+Watchlist

next ticker · + or scroll to zoom · pan · 0 reset

▲ buy   ▼ sell  ·  size ≈ trade size  ·  moving averages · click the buttons above to hide them

Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.4%
Next 1 week
+0.1%
Next 1 month
-1.1%
Seasonality
Weak window historically
Next 30 days (to Oct 15): -12.1% median, 25% of the last 12 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 42
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.11%/day.
Mean-reversion stats →
1-month breakdown — Market · β 1.91 -0.9% · Seasonal tilt -0.2%
$3M/day volume 96% volatility +129% 1-year
52-week range · 61% of the way up · -28% from the high
$0.94$3.23

Congressional trades in FATE Full tracker →

1 member · 0 buys / 1 sells · $1K–$15K disclosed · latest filing Feb 24, 2023.

SELL DG Daniel Goldman · traded Jan 31, 2023 $1K–$15K

Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.